Dr. Audrey Smargiassi

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Audrey Smargiassi. Improve your application with a focused, well-structured draft.

Biography

Audrey Smargiassi's research primarily focuses on health risks and population impacts of various environmental factors such as environmental noise, air pollutants, and climate change. She has led the development of diverse methodologies to estimate exposure of large populations, employing statistical methods, numerical approaches, and GIS satellite imagery in areas like heat, ozone, and fine particulate matter. Smargiassi is a board member and co-leader of the noise group within the Canadian Urban Environmental Health Research Consortium (CANUE) and has directed multiple epidemiological studies using government health data. She constructed several retrospective population-based cohorts in Quebec to link environmental exposures with health outcomes, including asthma incidence and dementia. Currently, she directs multidisciplinary projects evaluating health impacts related to transportation, urban greening, and land use scenarios. Her goal is to provide evidence-based recommendations for mitigating health impacts from environmental exposures and to inform health protection programs.

Research Interests

Experience

Professor

2012-01-01 — Present

Université de Montréal • Montréal, QC, Canada

Full professor in the Department of Environmental Health and Occupational Health at the School of Public Health.

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.